Life Summary
Lee Sung-joo is the CEO of Orum Therapeutics.

He was born on December 8, 1974.

After majoring in biochemistry at Yonsei University, he earned a Ph.D. in biophysics from the University of California, Berkeley.

He completed a two-year postdoctoral research program in the Department of Chemistry at Stanford University.

He joined LG Life Sciences as a researcher and later moved to Sanofi, where he served as Head of R&D for Asia-Pacific and Korea.

In 2016, he founded Orum Therapeutics, a company dedicated to researching and developing degrader-antibody conjugates (DAC).

He is regarded as a symbolic figure who demonstrated the potential for domestic biotech companies in new drug development to strike major deals with global pharmaceutical firms.

He now faces the challenges of securing clinical success and continuously expanding the company’s pipeline.

#OrumTherapeutics #LeeSungjoo #biotech #drugdevelopment #pharma #DAC #YonseiUniversity #UCBerkeley #Stanford #Sanofi #LGScience